Global disparities in public health guidance for the use of Covid-19 vaccines in pregnancy
Bibliographic Data
INTRODUCTION: Gaps in information about the safety and efficacy of COVID-19 vaccines in pregnancy have led to substantial global variation in public health guidance regarding the use of COVID-19 vaccines in pregnancy over the course of the pandemic. METHODS: We conducted systematic screenings of public health authorities' websites across 224 countries and territories every 3 weeks to track the development of policies on COVID-19 vaccine use in pregnancy. Policies were categorised using a 1-5 permissiveness scale, with 1 indicating policies that recommended use, and 5 indicating policies that recommended against use. RESULTS: As of 30 September 2021, 176 countries/territories had issued explicit guidance on COVID-19 vaccine use in pregnancy, with 38% recommending use, 28% permitting use, 15% permitting use with qualifications, 2% not recommending but with exceptions, and 17% not recommending use whatsoever. This represented a significant shift from May 2021, when only 6% of countries/territories with such policies recommended the use of COVID-19 vaccines in pregnancy (p<0.001). However, no policy positions could be found for 21% of all countries and territories, the vast majority being low and middle income. Policy positions also varied widely by vaccine product, with Pfizer/BioNTech and Moderna vaccines being most commonly recommended or permitted. CONCLUSION: Our study highlights the evolution of policies regarding COVID-19 vaccine use in pregnancy over a 5-month period in 2021, the role of pregnancy-specific data in shaping these policies and how inequities in access for pregnant people persist, both within countries and globally
Disease · Economic growth · Economics · Environmental health · Family medicine · Geography · Global health · Pandemic · Political science · Pregnancy · Public health · COVID-19 Impact on Reproduction · Medicine · Nursing · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy
Sars-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic
A qualitative inquiry in understanding trusted media sources to reduce vaccine hesitancy among Kenyans
Associations of Covid-19 vaccination during pregnancy with adverse neonatal and maternal outcomes
Assessing the role of Australia’s Pharmaceutical Benefits Scheme as a tool for addressing inequality in access to medications and allocation of public funds for pregnant women
Covid-19 vaccination in pregnancy
Gender equity and Covid-19 vaccine policies for pregnant people
Vaccines protect both you and your newborn
| Unique citing works | 7 |
|---|---|
| Citations per year | 2,33 |
| Citation span | 2023 - 2025 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 7 |